The phase II clinical study, which evaluated Microcyn[R] Technology for the treatment of mildly infected diabetic foot ulcers, was recently completed. This phase II randomized, controlled trial, which was undertaken by Oculus Innovative Sciences Inc, enrolled a total of 67 patients.
Patients were ...